The success of Ghana’s drive to manufacture vaccines locally may depend not only on scientific breakthroughs and investment but also on its ability to overcome decades of public scepticism and misinformation surrounding vaccines.
The Presiding Member of the Ho West District Assembly, Kasim Osman Adamu, believes local vaccine production could become a game-changer in restoring confidence in vaccination programmes and encouraging wider public acceptance of life-saving immunisation interventions.
His comments come as Ghana intensifies efforts to produce its first locally manufactured vaccine by the first quarter of 2027 through a partnership involving the Ghana National Vaccine Institute (GNVI), the World Health Organization (WHO), local pharmaceutical companies, and development partners under the PharmaVax Ghana Programme.
According to Hon. Adamu, although imported vaccines have played a critical role in protecting Ghanaians against infectious diseases over the years, many citizens continue to harbour doubts about products developed and manufactured outside the country.
He noted that public mistrust, fuelled by misinformation and conspiracy theories, remains one of the biggest obstacles to vaccine acceptance in many communities.
“Many people have confidence in our healthcare professionals, scientists and researchers. When vaccines are produced here in Ghana, people will be more assured that adequate research, testing and quality checks have been carried out before they are administered to the public,” he said in an interview.
The Ho West Presiding Member observed that while vaccine hesitancy is a global challenge, concerns among some Ghanaians often stem from misconceptions about the intentions behind vaccines imported from foreign countries.
He said narratives suggesting that certain vaccines are designed to harm Africans or reduce fertility rates continue to circulate in some communities despite the absence of scientific evidence to support such claims.
“Some people discourage others from taking vaccines because they do not trust products that come from outside the country. These misconceptions continue to influence public attitudes and affect vaccine uptake,” he explained.
Hon. Adamu argued that local vaccine manufacturing could help address such concerns by giving citizens a greater sense of ownership and confidence in the country’s healthcare interventions.
He further stated that Ghana possesses the human resource capacity needed to undertake vaccine research, development and production, citing the country’s highly trained healthcare professionals and scientists.
According to him, the move towards vaccine sovereignty represents a significant opportunity for Ghana to strengthen its healthcare system, reduce dependence on foreign suppliers, and improve national preparedness for future disease outbreaks and health emergencies.
Beyond local production, Hon. Adamu stressed the need for sustained public education and community engagement to address fears and misinformation that often accompany vaccination campaigns.
He observed that rumours tend to flourish when people are not adequately informed about the purpose, safety, and benefits of vaccines.
“The major challenge is that enough education is sometimes not provided before vaccines are introduced into communities. When people do not fully understand why a vaccine is being administered, misinformation spreads easily,” he noted.
The Presiding Member called on health authorities, community leaders, and the media to intensify sensitisation efforts and ensure that accurate information reaches the public before and during vaccine rollouts.
He particularly highlighted the role of healthcare professionals as trusted sources of information capable of helping citizens make informed decisions.
“If anyone wants clarification on vaccines, the first point of contact should be a health worker because they have the expertise and knowledge to provide the right information,” he said.
Hon. Adamu also praised the Food and Drugs Authority (FDA) for its regulatory oversight role and expressed confidence in the institution’s ability to ensure that any vaccines produced locally meet internationally accepted safety and quality standards.
He noted that the FDA’s stringent approval and monitoring processes provide an additional layer of assurance for the public.
While acknowledging the progress made in expanding vaccine access across the country through community outreach programmes and household visits by healthcare workers, he maintained that trust remains the missing link in achieving optimal vaccine coverage.
He therefore urged government and stakeholders involved in the local vaccine manufacturing agenda to remain committed to the initiative despite potential challenges.
According to him, the combination of local production, effective regulation, and continuous public education could significantly improve public confidence in vaccines and strengthen Ghana’s healthcare system.
“I want to encourage government and all agencies involved to continue their efforts. With education, community engagement and sensitisation, our people will accept locally manufactured vaccines and support their use,” he stated.
As Ghana moves closer to producing its first home-grown vaccine, Hon. Adamu believes the initiative has the potential to become a landmark achievement in the country’s public health history—one that not only reduces dependence on imports but also helps rebuild public trust in vaccines at a time when misinformation remains a growing threat to health interventions worldwide.
FRRG rejects legal basis for GoldBod’s environmental restoration initiative
Black Stars playing against England is a motivation, I’m certain they’ll…
